{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T21:17:32Z","timestamp":1717449452332},"reference-count":12,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Veterinary Journal"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.tvjl.2014.01.012","type":"journal-article","created":{"date-parts":[[2014,2,2]],"date-time":"2014-02-02T04:23:51Z","timestamp":1391315031000},"page":"195-196","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Spinosad is a potent inhibitor of canine P-glycoprotein"],"prefix":"10.1016","volume":"200","author":[{"given":"Johannes A.","family":"Schrickx","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tvjl.2014.01.012_b0005","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0014-4827(91)90452-Z","article-title":"Restoration of daunomycin retention in multidrug-resistant P388 cells by submicromolar concentrations of SDZ PSC 833, a nonimmunosuppressive cyclosporin derivative","volume":"196","author":"Boesch","year":"1991","journal-title":"Experimental Cell Research"},{"key":"10.1016\/j.tvjl.2014.01.012_b0010","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1124\/dmd.110.034827","article-title":"Pharmacokinetic interaction of the antiparasitic agents ivermectin and spinosad in dogs","volume":"39","author":"Dunn","year":"2011","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.tvjl.2014.01.012_b0015","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/clpt.2008.195","article-title":"Drug\u2013drug interactions mediated through P-glycoprotein: Clinical relevance and in vitro\u2013in vivo correlation using digoxin as a probe drug","volume":"85","author":"Fenner","year":"2009","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.tvjl.2014.01.012_b0020","first-page":"4595","article-title":"In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative","volume":"53","author":"Hyafil","year":"1993","journal-title":"Cancer Research"},{"key":"10.1016\/j.tvjl.2014.01.012_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.109.002014","article-title":"Xenobiotic, bile acid, and cholesterol transporters: Function and regulation","volume":"62","author":"Klaassen","year":"2010","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.tvjl.2014.01.012_b0030","doi-asserted-by":"crossref","first-page":"814","DOI":"10.2460\/ajvr.73.6.814","article-title":"Evaluation of the biliary and brain distribution of technetium Tc 99m sestamibi in healthy dogs with the ABCB1 wildtype genotype before and after treatment with spinosad","volume":"73","author":"Mackay","year":"2012","journal-title":"American Journal of Veterinary Research"},{"key":"10.1016\/j.tvjl.2014.01.012_b0035","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.mam.2012.10.012","article-title":"Transporter biology in drug approval: Regulatory aspects","volume":"34","author":"Maeda","year":"2013","journal-title":"Molecular Aspects of Medicine"},{"key":"10.1016\/j.tvjl.2014.01.012_b0040","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1365-2885.2011.01270.x","article-title":"A porcine lymphocyte model for P-gp inhibition studies","volume":"34","author":"Schrickx","year":"2011","journal-title":"Journal of Veterinary Pharmacology and Therapeutics"},{"key":"10.1016\/j.tvjl.2014.01.012_b0045","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ejphar.2008.03.014","article-title":"Implications of ABC transporters on the disposition of typical veterinary medicinal products","volume":"585","author":"Schrickx","year":"2008","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.tvjl.2014.01.012_b0050","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1124\/dmd.112.049577","article-title":"Retrospective analysis of P-glycoprotein-mediated drug\u2013drug interactions at the blood\u2013brain barrier in humans","volume":"41","author":"Sugimoto","year":"2013","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.tvjl.2014.01.012_b0055","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1002\/jps.22652","article-title":"Establishment of in vitro P-glycoprotein inhibition assay and its exclusion criteria to assess the risk of drug\u2013drug interaction at the drug discovery stage","volume":"100","author":"Sugimoto","year":"2011","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.tvjl.2014.01.012_b0060","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/jvp.12039","article-title":"Masitinib reverses doxorubicin resistance in canine lymphoid cells by inhibiting the function of P-glycoprotein","volume":"36","author":"Zandvliet","year":"2013","journal-title":"Journal of Veterinary Pharmacology and Therapeutics"}],"container-title":["The Veterinary Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023314000379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023314000379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T19:57:26Z","timestamp":1538855846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090023314000379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S1090023314000379"],"URL":"https:\/\/doi.org\/10.1016\/j.tvjl.2014.01.012","relation":{},"ISSN":["1090-0233"],"issn-type":[{"value":"1090-0233","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spinosad is a potent inhibitor of canine P-glycoprotein","name":"articletitle","label":"Article Title"},{"value":"The Veterinary Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tvjl.2014.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}